Back to News
Market Impact: 0.6

Truist cuts Analog Devices price target to $219, maintains hold

ADITFCEVRPIPR
Analyst EstimatesAnalyst InsightsCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsTechnology & InnovationCapital Returns (Dividends / Buybacks)
Truist cuts Analog Devices price target to $219, maintains hold

Truist Securities lowered its price target on Analog Devices (ADI) from $248 to $219, maintaining a Hold rating, after the company's strong Q1 results and Q2 guidance were overshadowed by investor concerns regarding automotive pull-ins, tariff impacts, and ambiguous full-year growth communication; this contrasts with other analysts like Evercore ISI who raised their price target, citing potential revenue growth, while others maintained neutral stances due to similar pull-in concerns. Despite the mixed analyst outlook, ADI reported solid Q1 results, raised Q2 guidance, and has a history of consistent dividend increases, though valuation and tariff worries warrant a cautious approach according to Truist.

Analysis

Truist Securities has revised its price target for Analog Devices (NASDAQ:ADI) downwards to $219.00 from $248.00, maintaining a Hold rating, despite the company reporting strong first-quarter results—revenue of $2.64 billion and EPS of $1.85, surpassing expectations—and issuing positive second-quarter guidance, forecasting revenues of $2.75 billion and EPS of $1.92. This cautious stance from Truist, which also adjusted its CY2026 EPS forecast for ADI to $8.77, stems from concerns over high investor expectations preceding the report, potential negative tariff impacts highlighted by automotive pull-ins, and ambiguous communication regarding full-year growth targets. Analog Devices currently trades at a premium P/E ratio of 57.19x. While management expresses confidence, particularly in the industrial sector's recovery, and InvestingPro data shows 22 analysts have revised earnings upward for the upcoming period, the market reaction reflects these specific anxieties. Other analysts offer varied perspectives: Evercore ISI raised its target to $280 (Outperform) citing potential revenue growth from declining EMS inventories, whereas Cantor Fitzgerald (Neutral, $250 PT) and Piper Sandler (Neutral, $215 PT) echoed concerns about order pull-ins. Benchmark remains bullish with a Buy rating and a $260 target, noting improved bookings. Despite these headwinds and mixed analyst sentiment (overall sentiment mildly positive but cautious), ADI's fundamentals include a healthy current ratio of 2.08x and a notable 22-year history of consecutive dividend increases, currently yielding 1.88%.